International Journal of Cancer Management

Published by: Kowsar

Analysis of Cytotoxic Activity and Synergistic Effect of Curcuma Longa Extract in Combination with Prednisolone on Acute Lymphoblastic Leukemia Cell Lines

Mohammad Esfini-Farahani 1 , Majid Farshdousti-Hagh 1 , * , Davood Bashash 2 , Somayeh Esmaeili 3 , Nasrin Dehghan- Nayeri 2 , Sorur Yazdanpanah 2 and Ahmad Gharehbaghian 2 , **
Authors Information
1 Immunology Research Center, Tabriz university of Medical Sciences, Tabriz, Iran
2 Department of Laboratory Hematology and Blood Bank, School of Allied Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Traditional Medicine and Materia Medica Research Center (TMRC), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Corresponding Authors:
Article information
  • International Journal of Cancer Management: November 2017, 10 (11); e14174
  • Published Online: November 30, 2017
  • Article Type: Research Article
  • Received: May 28, 2017
  • Revised: July 7, 2017
  • Accepted: November 18, 2017
  • DOI: 10.5812/ijcm.14174

To Cite: Esfini-Farahani M, Farshdousti-Hagh M, Bashash D, Esmaeili S, Dehghan- Nayeri N, et al. Analysis of Cytotoxic Activity and Synergistic Effect of Curcuma Longa Extract in Combination with Prednisolone on Acute Lymphoblastic Leukemia Cell Lines, Int J Cancer Manag. 2017 ; 10(11):e14174. doi: 10.5812/ijcm.14174.

Copyright © 2017, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Bindreither D, Ecker S, Gschirr B, Kofler A, Kofler R, Rainer J. The synthetic glucocorticoids prednisolone and dexamethasone regulate the same genes in acute lymphoblastic leukemia cells. BMC Genomics. 2014;15:662. doi: 10.1186/1471-2164-15-662. [PubMed: 25103118].
  • 2. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008;371(9617):1030-43. doi: 10.1016/S0140-6736(08)60457-2. [PubMed: 18358930].
  • 3. Samuels AL, Beesley AH, Yadav BD, Papa RA, Sutton R, Anderson D, et al. A pre clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia. Blood Cancer J. 2014;4:232. doi: 10.1038/bcj.2014.52. [PubMed: 25083816].
  • 4. Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet. 2013;381(9881):1943-55. doi: 10.1016/S0140-6736(12)62187-4. [PubMed: 23523389].
  • 5. Koohi F, Salehiniya H, Shamlou R, Eslami S, Ghojogh ZM, Kor Y, et al. Leukemia in Iran: Epidemiology and Morphology Trends. Asian Pac J Cancer Prev. 2015;16(17):7759-63. [PubMed: 26625794].
  • 6. Pui CH, Sandlund JT, Pei D, Campana D, Rivera GK, Ribeiro RC, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood. 2004;104(9):2690-6. doi: 10.1182/blood-2004-04-1616. [PubMed: 15251979].
  • 7. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med. 2004;350(15):1535-48. doi: 10.1056/NEJMra023001. [PubMed: 15071128].
  • 8. Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood. 2001;97(5):1211-8. [PubMed: 11222362].
  • 9. Felice MS, Zubizarreta PA, Alfaro EM, Sackmann-Muriel F. Childhood acute lymphoblastic leukemia: prognostic value of initial peripheral blast count in good responders to prednisone. J Pediatr Hematol Oncol. 2001;23(7):411-5. [PubMed: 11878573].
  • 10. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354(2):166-78. doi: 10.1056/NEJMra052603. [PubMed: 16407512].
  • 11. Spahn JD, Kamada AK. Special considerations in the use of glucocorticoids in children. Pediatr Rev. 1995;16(7):266-72. doi: 10.1542/pir.16-7-266.
  • 12. Stanbury RM, Graham EM. Systemic corticosteroid therapy side effects and their management. Br J Ophthalmol. 1998;82(6):704-8. doi: 10.1136/bjo.82.6.704.
  • 13. Ali RE, Rattan SI. Curcumin's biphasic hormetic response on proteasome activity and heat-shock protein synthesis in human keratinocytes. Ann N Y Acad Sci. 2006;1067:394-9. doi: 10.1196/annals.1354.056. [PubMed: 16804017].
  • 14. Desai AG, Qazi GN, Ganju RK, El-Tamer M, Singh J, Saxena AK, et al. Medicinal plants and cancer chemoprevention. Curr Drug Metab. 2008;9(7):581-91. [PubMed: 18781909].
  • 15. Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta. 2013;1830(6):3670-95. doi: 10.1016/j.bbagen.2013.02.008. [PubMed: 23428572].
  • 16. Strimpakos AS, Sharma RA. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal. 2008;10(3):511-45. doi: 10.1089/ars.2007.1769. [PubMed: 18370854].
  • 17. Michalak M, Paulo M, Pudlo K. Therapeutic significance of curcumin and its role in cancer treatment. J Pre Clin Clin Res. 2012;6(2).
  • 18. Amalraj A, Pius A, Gopi S, Gopi S. Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives - A review. J Tradit Complement Med. 2017;7(2):205-33. doi: 10.1016/j.jtcme.2016.05.005. [PubMed: 28417091].
  • 19. Liu CL, Ho KY, Wang LF, Chien CY, Wang HM. The efficacy of varied oral steroid doses on the treatment of sudden sensorineural hearing loss. J Int Adv Otol. 2014;10(2):113-7. doi: 10.5152/iao.2014.26.
  • 20. Lambrou GI, Vlahopoulos S, Papathanasiou C, Papanikolaou M, Karpusas M, Zoumakis E, et al. Prednisolone exerts late mitogenic and biphasic effects on resistant acute lymphoblastic leukemia cells: Relation to early gene expression. Leuk Res. 2009;33(12):1684-95. doi: 10.1016/j.leukres.2009.04.018. [PubMed: 19450877].
  • 21. Costa-Lotufo LV, Khan MT, Ather A, Wilke DV, Jimenez PC, Pessoa C, et al. Studies of the anticancer potential of plants used in Bangladeshi folk medicine. J Ethnopharmacol. 2005;99(1):21-30. doi: 10.1016/j.jep.2005.01.041. [PubMed: 15848015].
  • 22. Cragg GM, Newman DJ. Antineoplastic agents from natural sources: achievements and future directions. Expert Opin Investig Drugs. 2000;9(12):2783-97. doi: 10.1517/13543784.9.12.2783. [PubMed: 11093353].
  • 23. Chen J, Wang FL, Chen WD. Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression. Mol Biol Rep. 2014;41(7):4583-94. doi: 10.1007/s11033-014-3329-9. [PubMed: 24604727].
  • 24. Reuter S, Eifes S, Dicato M, Aggarwal BB, Diederich M. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol. 2008;76(11):1340-51. doi: 10.1016/j.bcp.2008.07.031. [PubMed: 18755156].
  • 25. Wang H, Geng QR, Wang L, Lu Y. Curcumin potentiates antitumor activity of L-asparaginase via inhibition of the AKT signaling pathway in acute lymphoblastic leukemia. Leuk Lymphoma. 2012;53(7):1376-82. doi: 10.3109/10428194.2011.649478. [PubMed: 22185211].
  • 26. Mishra D, Singh S, Narayan G. Curcumin Induces Apoptosis in Pre-B Acute Lymphoblastic Leukemia Cell Lines Via PARP-1 Cleavage. Asian Pac J Cancer Prev. 2016;17(8):3865-9. [PubMed: 27644631].
  • 27. Pimentel Gutierrez HJ, Bobadilla Morales L, Barba Barba CC, Ortega De La Torre C, Sanchez Zubieta FA, Corona Rivera JR, et al. Curcumin potentiates the effect of chemotherapy against acute lymphoblastic leukemia cells via downregulation of NF kappaB. Oncol Lett. 2016;12(5):4117-24. doi: 10.3892/ol.2016.5217. [PubMed: 27895780].
  • 28. Wu GQ, Chai KQ, Zhu XM, Jiang H, Wang X, Xue Q, et al. Anti cancer effects of curcumin on lung cancer through the inhibition of EZH2 and NOTCH1. Oncotarget. 2016;7(18):26535-50. doi: 10.18632/oncotarget.8532.
  • 29. Yue GG, Chan BC, Hon PM, Lee MY, Fung KP, Leung PC, et al. Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa. Food Chem Toxicol. 2010;48(8-9):2011-20. doi: 10.1016/j.fct.2010.04.039. [PubMed: 20438793].
  • 30. Guo Y, Li Y, Shan Q, He G, Lin J, Gong Y. Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT/mTOR pathway and BCR/ABL gene expression in Ph+ acute lymphoblastic leukemia. Int J Biochem Cell Biol. 2015;65:1-11. doi: 10.1016/j.biocel.2015.05.003. [PubMed: 25979368].
  • 31. Hashim FJ, Shawkat MS, Al Jewari H. Cytotoxicity of curcumin against leukemic cell lines via apoptosis activity. Current Res J Biol Sci. 2012;4(1):60-4.
  • 32. Papiez MA, Krzysciak W, Szade K, Bukowska-Strakova K, Kozakowska M, Hajduk K, et al. Curcumin enhances the cytogenotoxic effect of etoposide in leukemia cells through induction of reactive oxygen species. Drug Des Devel Ther. 2016;10:557-70. doi: 10.2147/DDDT.S92687. [PubMed: 26893544].
  • 33. Spijkers-Hagelstein JA, Schneider P, Pinhancos SM, Garrido Castro P, Pieters R, Stam RW. Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101. Eur J Cancer. 2014;50(9):1665-74. doi: 10.1016/j.ejca.2014.03.011. [PubMed: 24703900].
  • 34. Syng-Ai C, Kumari AL, Khar A. Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther. 2004;3(9):1101-8. [PubMed: 15367704].
  • 35. Delbridge AR, Grabow S, Strasser A, Vaux DL. Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nat Rev Cancer. 2016;16(2):99-109. doi: 10.1038/nrc.2015.17. [PubMed: 26822577].
  • 36. Guo LD, Chen XJ, Hu YH, Yu ZJ, Wang D, Liu JZ. Curcumin inhibits proliferation and induces apoptosis of human colorectal cancer cells by activating the mitochondria apoptotic pathway. Phytother Res. 2013;27(3):422-30. doi: 10.1002/ptr.4731. [PubMed: 22628241].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments